Events and Presentations

Documents
September 2023 Corporate Presentation
Clinical And Biological Activity Of FLX475, An Oral CCR4 Antagonist, In Combination With Pembrolizumab In Advanced Cancer, CICON 2023
Clinical and Biological Activity of FLX475, an Oral CCR4 Antagonist, in Advanced Cancer, ASCO 2023
Phase 1/2 study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer, ESMO-IO 2022
2022 American Academy of Dermatology (AAD) Annual Meeting Presentation, March 26, 2022
Inflammatory Skin Disease Summit (ISDS) Presentation, November 3, 2021
RPT193 2021 EADV Congress Presentation, September 30, 2021
RAPT Therapeutics RPT193 Phase 1 B Data Presentation
RAPT Therapeutics Initial Data Readout for FLX475
RPT193 Society for Investigative Dermatology Presentation, May 15, 2020

Date	Event Details
Sep 26, 2023 at 10:35 AM EDT	Cantor Global Healthcare Conference Click here for webcast
Sep 11, 2023 at 2:00 PM EDT	H.C. Wainwright 25th Annual Global Investment Conference Click here for webcast
Sep 6, 2023 at 8:00 AM EDT	Wells Fargo 2023 Healthcare Conference Click here for webcast
Jun 12, 2023 at 1:20 PM PDT	Goldman Sachs Global Healthcare Conference Click here for webcast
Feb 14, 2023 at 1:40 PM EST	SVB Securities Global Biopharma Conference Click here for webcast
Jan 10, 2023 at 3:00 PM PST	41st Annual J.P. Morgan Healthcare Conference Click here for webcast
Jun 14, 2021 at 8:30 AM EDT	RAPT Therapeutics RPT193 Phase 1 B Data Call Click here for webcast Supporting Materials RAPT Therapeutics RPT193 Phase 1 B Data Presentation 1 MB